SERTRALINE HYDROCHLORIDE
- Product NDC
- 50090-3945
- 11-digit product format
- 500903945
- Labeler code
- 50090
- Product ID
- 50090-3945_d7736b89-1ba0-498e-802d-703f700ac9f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SERTRALINE HYDROCHLORIDE
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202825
- Marketing category
- ANDA
- Marketing start
- 2017-02-09
- Marketing end
- 0000-00-00
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Cytochrome P450 2D6 Inhibitors [MoA], Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-3945-0 | 50090394500 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-3945-0) | 2018-12-10 | 0000-00-00 | No | No | Current |
| 50090-3945-1 | 50090394501 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3945-1) | 2017-02-09 | 0000-00-00 | No | No | Current |
| 50090-3945-2 | 50090394502 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-3945-2) | 2017-02-09 | 0000-00-00 | No | No | Current |